Company / Total Debt
Haemonetics Total Debt History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$1.2B
FY2025
5-year range
$559.4M / $1.2B
FY2021-FY2025
Trend
+56.2%
vs FY2024
Sector context
#51 of 102
Health Care
What the data says
At $1.2B, Haemonetics's total debt ranks #52 of 102 in the Health Care sector. Total Debt has increased for 3 consecutive years, from $559M in FY2022 to $1.2B in FY2025.
Based on SEC 10-K filings.
$1.2B in FY2025 with a 5-year CAGR of +32.5%.
Increased from $754M to $1.2B over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +30.6%
- 5-Year CAGR
- +32.5%
- 10-Year CAGR
- -
Sector benchmark
#52 of 102 in Health CareTop 50% of 102This company $1.2B Sector average $4.5B
▼
-72.2% below sector average
Key checks
Key Insights
- Haemonetics's total debt has grown for 3 consecutive years.
- 5-year CAGR of +32.5%, indicating consistent growth.
- In FY2025, total debt increased 56.2% year-over-year.
- Ranks #51 out of 102 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | +56.2% |
| FY2024 | $797.6M | +5.8% |
| FY2023 | $754.1M | +34.8% |
| FY2022 | $559.4M | -19.0% |
| FY2021 | $690.6M | +126.0% |
| FY2020 | $305.5M | -5.3% |
| FY2019 | $322.5M | +442.6% |
| FY2018 | $59.4M | -81.2% |
| FY2017 | $315.8M | -22.7% |
| FY2016 | $408.5M | -5.1% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026